Display options
Share it on

Transl Behav Med. 2011 Jun;1(2):303-12. doi: 10.1007/s13142-011-0030-6.

Adaptation and implementation of an evidence-based behavioral medicine program in diverse global settings: The Williams LifeSkills experience.

Translational behavioral medicine

Redford B Williams, Virginia P Williams

Affiliations

  1. Duke University Medical Center, Durham, NC USA.

PMID: 24073053 PMCID: PMC3717644 DOI: 10.1007/s13142-011-0030-6

Abstract

Epidemiological research has documented the health-damaging effects of psychosocial factors like hostility, depression, anxiety, job stress, social isolation and low socioeconomic status. Several studies suggest that behavioral interventions can reduce levels of these psychosocial factors. Herein we describe the translational process whereby the Williams LifeSkills® (WLS(®)) program and products for reducing psychosocial risk factors have been developed and tested in clinical trials in the U.S. and Canada and then adapted for other cultures and tested in clinical trials in other countries around the world. Evidence from published controlled and observational trials of WLS(®) products in the U.S. and elsewhere shows that persons receiving coping skills training using WLS(®) products have consistently reported reduced levels of psychosocial risk factors. In two controlled trials, one for caregivers of a relative with Alzheimer's Disease in the U.S. and one for coronary bypass surgery patients in Singapore, WLS(®) training also produced clinically significant blood pressure reductions. In conclusion, WLS(®) products have been shown in controlled and observational trials to produce reduced levels of both psychosocial and cardiovascular stress indices. Ongoing research has the potential to show that WLS(®) products can be an effective vehicle for the delivery of stress reduction and mental health services in developing countries.

Keywords: Behavioral interventions; Biological mechanisms; Psychosocial stress factors; Translational research; Williams LifeSkills

References

  1. Int J Behav Med. 2010 Mar;17(1):25-32 - PubMed
  2. Psychosom Med. 1991 Jul-Aug;53(4):386-92 - PubMed
  3. Am J Cardiol. 1994 Aug 1;74(3):298-300 - PubMed
  4. Psychosom Med. 1983 May;45(2):109-14 - PubMed
  5. Psychosom Med. 2006 Nov-Dec;68(6):816-23 - PubMed
  6. Psychosom Med. 1983 Mar;45(1):59-63 - PubMed
  7. J Occup Health. 2009;51(5):437-42 - PubMed
  8. Am J Epidemiol. 1992 Jul 15;136(2):136-45 - PubMed
  9. J Consult Clin Psychol. 2007 Aug;75(4):657-62 - PubMed
  10. Stroke. 2001 Jun;32(6):1263-70 - PubMed
  11. Am Heart J. 1986 Oct;112(4):653-65 - PubMed
  12. Psychosom Med. 1980 Nov;42(6):539-49 - PubMed
  13. Arch Gen Psychiatry. 1997 Jun;54(6):543-8 - PubMed
  14. Circulation. 1992 Jun;85(6):2045-53 - PubMed
  15. Psychosom Med. 2010 Nov;72(9):897-904 - PubMed
  16. JAMA. 1993 Oct 20;270(15):1819-25 - PubMed
  17. Arch Intern Med. 1997 Oct 27;157(19):2213-23 - PubMed
  18. Psychosom Med. 1998 Sep-Oct;60(5):586-91 - PubMed
  19. Annu Rev Public Health. 1994;15:381-411 - PubMed
  20. Psychosom Med. 2003 Mar-Apr;65(2):201-10 - PubMed
  21. BMJ. 1999 May 29;318(7196):1460-7 - PubMed
  22. Diabetes Care. 2002 May;25(5):835-9 - PubMed
  23. Psychosom Med. 1998 Jan-Feb;60(1):78-88 - PubMed
  24. Lancet. 2009 Jun 13;373(9680):2041-53 - PubMed
  25. JAMA. 1992 Jan 22-29;267(4):520-4 - PubMed
  26. Arch Gen Psychiatry. 1993 Sep;50(9):681-9 - PubMed
  27. Circulation. 2004 Jul 6;110(1):74-8 - PubMed
  28. Am J Public Health. 1999 Sep;89(9):1322-7 - PubMed
  29. Health Psychol. 1999 Jul;18(4):416-20 - PubMed
  30. Am Heart J. 2005 Sep;150(3):602-9 - PubMed
  31. Hypertension. 2006 Mar;47(3):391-5 - PubMed
  32. Lancet. 2004 Sep 11-17;364(9438):953-62 - PubMed
  33. Psychosom Med. 2000 Jan-Feb;62(1):7-16 - PubMed
  34. Acad Psychiatry. 2008 May-Jun;32(3):188-93 - PubMed
  35. Lancet. 2004 Sep 11-17;364(9438):937-52 - PubMed

Publication Types

Grant support